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Abstract Protein argininemethyltransferase 1 (PRMT1) is an
arginine-specific protein methyltransferase that methylates a
number of proteins involved in transcription and RNAmetab-
olism in all parasitic helminths, including the human blood
fluke, Schistosoma japonicum . To characterize the role of
PRMT1 in the development of S. japonicum and to investi-
gate its influence on parasite–host interactions, we cloned and
expressed the protein from an existing cDNA library. We
report that the clone encoded a polypeptide comprising 360
amino acids with a predictive Mr of 42 kDa. Bioinformatic
analyses predicted that there were many potential B cell
epitopes and T cell epitopes associated with SjcPRMT1, sug-
gesting it is a potential candidate molecule for vaccine devel-
opment. The purified recombinant protein of S. japonicum
(Chinese strain) (rSjcPRMT1) was found to be immunogenic,
eliciting a high antibody titer in mice. Moreover, Western blot
analysis revealed that the protein could be recognized by the
sera of infected mice. Using flow cytometry, we showed that
rSjcPRMT1 slightly upregulated the expression of CD40,
CD80, CD86, and MHC-II molecules of mouse bone
marrow-derived dendritic cell (BMDC), indicating that
rSjcPRMT1 could induce mouse BMDC to mature and, there-
fore, activate their immune response. Overall, our findings
provide evidence that rSjcPRMT1 could serve as an effective
candidate molecule for the development of a vaccine against
infection with S. japonicum .
Introduction
Schistosomiasis is a widespread infectious disease that con-
stitutes a serious public health problem worldwide. While
significant progress has been made in treatment of the disease
with safer and more effective drugs now available, treatment
does not prevent reinfection (Patz et al. 2000; McManus and
Loukas 2008). Moreover, reinfection rates are high, which
results in continuing outbreaks of high prevalence and high
associated morbidity (McManus 2005). Vaccination offers an
effective alternative to the treatment of schistosomiasis.
However, to date, vaccines have not been used in clinical
trials because their protective efficiency remains low (Xin
et al. 2006; Siddiqui et al. 2011). Hence, there is an urgent
need to identify and develop candidate molecules for use in
future vaccines to protect again schistosomiasis. The reed
vole, Microtus fortis (herein referred to as Mf), is the only
known mammalian host in which schistosomes of
Schistosoma japonicum are unable to mature, and thus, cause
significant pathogenesis in hosts (Liu et al. 2001; Sun et al.
2004; Peng et al. 2011). Therefore, investigating the immu-
nogenetic response of Mf to schistosome infection could help
to identify new candidate vaccine molecules that protect this
species from the debilitating effects of schistosomiasis.
Previously, we constructed and screened the cDNA library
of schistosomu using the serum of wild-typeMf and identified
26 candidate genes likely involved in the immune response of
Mf, including protein arginine methyltransferase 1 (PRMT1),
high mobility group box-1(HMGB1), cytochrome b5, mito-
chondrion coding region, 16 S. japonicum proteins of un-
known function, and six novel encoded proteins (data not
shown). Protein arginine methyltransferase 1 (PRMT1) is a
type I enzyme that catalyzes the transfer of an S-adenosyl-L-
methionine to a broad spectrum of substrates, including his-
tones, RNA-transporting proteins, and nuclear hormone
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receptor coactivators (Chiou et al. 2007). Protein arginine
methylation is also involved in regulating various cellular
processes including transcription regulation, DNA repair,
RNA processing, and signal transduction (Bedford and
Richard 2005; Hung et al. 2004; Krause et al. 2007). Hence,
it is likely that this molecule could prove effective in the
development of a vaccine against schistosomiasis. However,
its role in host immune regulation following infection with
S. japonicum infection remains elusive. In the present study,
we aimed to characterize the role of PRMT1 in the develop-
ment of S. japonicum and its influence on parasite–host
interactions. To do so, we cloned and expressed the protein
PRMT1 of S. japonicum (Chinese strain) (rSjcRPMI1) from
our existing cDNA library and investigated its effects on
immune responses in this host species.
Materials and methods
Ethics statement
This study was carried out in strict accordance with the rec-
ommendations in the Guide for the Care and Use of
Laboratory Animals of the National Institute of Parasitic
Diseases, Chinese Center for Disease Control and
Prevention. The protocol was approved by the Laboratory
Animal Welfare & Ethics Committee (LAWEC), National
Institute of Parasitic Diseases, Chinese Center for Diseases
Control and Prevention (permit number: IPD 2011-006). All
surgery was performed under sodium pentobarbital anesthe-
sia, and all efforts were made to minimize suffering.
Amplification and cloning the gene encoding the target
protein
RNA was isolated from adult S. japonicum (Chinese strain)
via digestion, ligation, and sequencing. The gene fragment
(SjcRPMI1) was then amplified by reverse transcription PCR
(RT-PCR) using the total RNA as a template. The specific
primers (sense primer: 5′-GCA GGA TCC ATG AAC GTT
AAA AAT GGA GAA GC-3′ and antisense primer: 5′-CGA
CTC GAG TCA GCG CAT GCG ATA ATT AAA C-3′,
which included a BamH I site and a Xho I site, respectively)
were designed according to the electronic elongation sequence
of SjcPRMT1. The amplification profile used was as follows:
95 °C for 5 min, followed by 35 cycles at 95 °C/45 s, 63 °C/
45 s, and 72 °C/1 min 20 s and 72 °C/5 min (final extension).
PCR experiments were performed on a programmable Easter-
win PCR system using Taq polymerase (Promega, America),
and the PCR products were separated on 1.0 % agarose gels
and visualized under UV light by ethidium bromide staining.
The PCR products were extracted from the agarose gel then
double-digested with BamH I and Xho I endonucleases and
cloned into the prokaryotic expression vector pET28a (Biotec,
Beijing, China). Following this the recombinant plasmid,
pET28a-SjcPRMT1 was isolated and confirmed by DNA
sequencing.
Prokaryotic expression and purification of the target protein
This plasmid was then transformed into Escherichia coli BL21
(DE3) (Biotec, Beijing, China). SjcPRMT1 was expressed as a
6His-SjcPRMT1 (His-SjcPRMT1) fusion protein upon
isopropyl-D-thiogalactopyranoside induction (1 mg/mL for
6 h). The recombinant protein was purified by affinity column
chromatography using a HISTrap™ FF resin column (GE
Healthcare, Milwaukee, WI, USA) followed by thrombin
(Novagen) cleavage. Protein samples were fractionated using
15 % sodium dodecyl sulfate polyacrylamide gel electropho-
resis (SDS–PAGE) and visualized by Coomassie brilliant blue
G-250 staining. The cleaved protein was excised from an SDS–
PAGE gel, and its identity was confirmed by mass spectrome-
try. The protein concentration was determined by the method of
Bradford (1976).
Western blotting analysis
The purified recombinant His-SjcPRMT1 fusion protein was
subjected to 15 % SDS–PAGE, electrotransferred to nitrocel-
lulose membrane (Osmonics), and probed with mouse anti-
SjcPRMT1 sera (1:1,500 dilution in phosphate-buffered saline
[PBS]) as the primary antibody and horseradish peroxidase-
conjugated rabbit anti-mouse immunoglobulin G (Sigma) as
the secondary antibody. The signal was detected by an
electrochemiluminescence Western blotting system (GE
Healthcare/Amersham Biosciences). In addition, the purified
recombinant SjcPRMT1 was probed with mouse serum
(1:500) infected with the cercariae of S. japonicum .
Dendritic cells stimulation and maturation
Dendritic cells (DC) are the most potent antigen-presenting
cells and play a major role in the initiation and regulation of
the adaptive immune response to antigens. The solution of
thrombin-cleaved SjcPRMT1 protein was filtered through a
0.22-μm syringe filter (Acrodisc, Pall, Auckland, USA) and
then applied to the Affinity Park™ Detoxi-gel TM Endotoxin
RemovingGel column (Pierce, USA) to remove the endotoxin
in the protein solution according to the manufacturer's instruc-
tions. This allowed the concentrations of SjcPRMT1 and the
endotoxin in the elution to be determined. After being cultured
for 8 days, the DCs derived from mouse bone marrow were
incubated with 0.05, 0.1, 1, or 10 μg/mL of rSjcPRMT1 for
24 h. Lipopolysaccharide (LPS; 0.1 μg/ml) and PBS were
used to replace the protein as the positive and negative control,
respectively.
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Phenotypic characterization of mouse bone marrow-derived
DC after stimulation with PRMT 1
The expression of surface molecules MHC-II and CD11c
on collected cells was analyzed using flow cytometry
(Calibar BD, USA). To determine the differences of the
expression of co-stimulation molecules of DCs, the
CD11c+ cells were purified using anti-CD11c antibody-
conjugated beads (Miltenyi, Germany). They were then
analyzed for the expression of CD40, CD80, CD86, and
MHC-II.
At each step of the staining, 5×105 cells were stained
with specific Abs for 30 min at 4 °C in 100 μL of PBS
containing 1 % of bovine serum albumin (BSA) and
0.1 % of sodium azide (PBS + BSA + NaN3). We used
fluorescein isothiocyanate (FITC) or phycoerythrin (PE)-
labeled monoclonal Abs, including PE-conjugated MHC
class II (I-Ab, mouse IgG2a, AF6-120.1), FITC-
conjugated CD11c (hamster IgG, HL3), PE-conjugated
CD40 (hamster IgM, HM40-3), FITC-conjugated CD80
(rat IgG2a, 1G10), and FITC-conjugated CD86 (rat
IgG2a, BL1). FITC- or PE-labeled mouse, rat, or hamster
IgG was substituted for specific Abs for the negative
controls. All Abs were purchased from Peprotech
(England).
Gene Runner (Hastings Software, Inc.) was used to predict
the secondary structure and the functional sites.
Results
Amplification and cloning of the gene encoding SjcPRMT1
RT–PCR amplification of SjcPRMT1 was successful with a
single band revealed by agarose gel electrophoresis of approx-
imately 1,100 bp size (Fig. 1a, lanes 1–3). This PCR product
was cloned into the pET-28a vector to generate the pET-28a-
SjcPRMT1 recombinant plasmid (confirmed by DNA se-
quencing and double digestion with BamH I and Xho I;
Fig. 1b, lanes 1–4).
Bioinformatics analysis of the target protein SjcPRMT1
Using a public analysis software in the website CBS (http://
www.cbs.dtu.dk/services/), a bioinformatic analysis of the
SjcPRMT1 protein showed that its secondary structure
contained numerous α-helix, β-turn, and β-sheet structures,
but no transmembrane structure (TM). Prosite motif research,
meanwhile, showed that this protein carried seven protein
kinase C phosphorylation sites, 3 N-myristoylation sites, 6
casein kinase II phosphorylation sites, 1 Asn-glycosylation site,
and 1 cAMP phosphorylation site. In addition, BepiPred 1.0
Server analysis (http://www.cbs.dtu.dk/services/BepiPred/)
predicted the presence of many potential B cell epitopes and
Tcell epitopes in the SjcPRMT1 protein, suggesting it may be a
good candidate for vaccine development.
Expression and Western blotting analysis
The recombinant SjcPRMT1 fusion protein was expressed in
E. coli BL21 (DE3) and purified by affinity column chroma-
tography. After dialysis, approximately 30 mg of purified
protein was obtained from 2,000 mL of culture. The final
concentration of the protein was 0.5 mg/mL in PBS. SDS–
PAGE showed that the size of the purified fusion recombinant
SjcPRMT1 was 42 kDa (Fig. 2a, lanes 4–7; Fig. 2b, lane 1).
Results of the Western blotting analysis showed that both the
anti-His-G HRP antibody and the sera from mouse infected
with cercaria of S. japonicum reacted with the purified recom-
binant SjcPRMT1 protein (Fig. 2c, lanes 2 and 3), showing a
band of approximately 42 kDa.
SjcPRMT1 upregulated the expression of MHC-II, CD40,
CD80, and CD86 in mouse BMDC
LPS induced DCmaturationwith upregulation surface expres-
sion of MHC-II, CD40, CD80, and CD86 (van der Kleij et al.
2002; Martinez et al. 2007). This was used as the positive
stimulation to evaluate the maturation of DCs incubated with
SjcPRMT-1. The phenotype of treated DCs was analyzed by
flow cytometry. rSjcPRMT-1 significantly activated DCs with
Fig. 1 Amplification and cloning
of SjcPRMT1. a RT–PCR results
of SjcPRMT1. The PCR product
was approximately 1,100 bp in
size. b Identification of the
recombinant plasmid of pET28a-
SjcPRMT1 by double digestion.
The recombinant plasmid DNA
was digested by BamH I and Xho I
M1, M2, M3, M4 are all DNA
markers
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upregulation of MHC-II, CD40, CD80, and CD86 (Fig. 3),
indicating that rSjcPRMT1 activated DCs and subsequently, T
cells.
Discussion
Vaccination offers an effective alternative to the medical treat-
ment of schistosomiasis, yet remains a poor therapeutic option
due to the lack of efficacy of current vaccines (Xin et al. 2006;
Siddiqui et al. 2011). Previously, we demonstrated that protein
arginine methyltransferase 1 (PRMT1) plays a role in protecting
the reed vole, M. fortis , from the negative physiological effects
of S. japonicum infection. In this study, we successfully cloned
and expressed the SjRPMI1 protein from our existing cDNA
library and found that rSjcPRMI 1 may serve as an effective
candidate molecule upon which to base the future development
of a vaccine against infection with S. japonicum .
Protein arginine methyltransferase 1 (PRMT1), also known
as HMT1 hnRNP methyltransferase-like 2, is an arginine-
specific protein methyltransferase that methylates a number of
proteins involved in transcription and other aspects of RNA
metabolism (Xu et al. 2003). It has been shown by three
different research groups to be a protein that interacts with
TIS21 and BTG1 in a yeast-2-hybrid screen (Lin et al. 1996),
to interact with the interferon-alpha receptor (Abramovich et al.
1997), and to be homologous to the yeast homolog Hmt1p
(Scott et al. 1998). PRMT1 is not required for adult viability but
is required for differentiation during embryogenesis: mice lack-
ing a functional PRMT1 gene die at an early stage of embryo-
genesis due to failure of the formation of the head and nervous
system (Pawlak et al. 2000). The critical nature of PRMT1 in
cellular function means that employing antibodies or vaccines
to inhibit PRMT1 is likely to result in toxic effects.
In this study, we found that SjcPRMT 1 shared 87 % ho-
mology to PRMT1 cloned from the closely related schistosome
parasite, S. mansoni . This Sm PRMT1 protein has previously
been demonstrated to methylate asymmetrically Arg-3 of his-
tone H4 in vitro and to play a role in nuclear receptor-mediated
chromatin remodeling and RNA transactions (Mansure et al.
2005). The similarity between Sj PRMT1 and Sm PRMT1 in
terms of nucleotide and protein sequences, and the presence of
an S-adenosylmethionine binding submotif, suggests that Sj
PRMT1 is likely to be the homolog of Sm PRMT1. In addition
to cloning and expression of Sj PRMT, we also obtained the
purified rSj PRMT 1 protein from E. coli . Previous studies
have shown that passive transfer of immunized sera among
hosts also confers a degree of protection (Moloney et al. 1987);
thus, it is assumed that antibodies in the immunized sera protect
against S. japonicum infection. The result of our antigenicity
assay showed that rSjcPRMT1 may be a potential candidate
molecule for vaccine development, as it was successfully
Fig. 2 Expression and
identification of SjcPRMT1. a
Analysis of recombinant
SjcPRMT1 by SDS–PAGE. M




induced by IPTG after 4 h, 3
pET28a-SjcPRMT1/BL21 before
IPTG inducing, 4–7 pET28a-
SjcPRMT1/BL21 induced by
IPTG after 1, 2, 4, and 7 h. b
SDS–PAGE analysis of purified
reSjcPRMT1. c Identification of
reSjcPRMT1. M protein marker,
1 normal mouse serum, 2 anti-
His-G HRP antibody, 3 serum
from mice infected with
S. japonicum
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probed by S. japonicum cercariae infected mouse serum. Han
et al. (2010) evaluated the protection effects of recombinant
PRMT1 against schistosomiasis japonica and found that the
protein had a good ability to induce antibodies in mice, which
resulted in worm burden reduced by 35.07 % and egg burden
reduced by 48.66 %.
PRMT1 gene was found to be expressed in the worm days
7, 13, 18, 23, 32, and 42 (Han et al. 2010) and especially a
comparative higher expression in the adult of day 18. In the
developmental stage of S. japonicum , male–female worm
pairing begins at the days 17 to 18, and then the female
matured and spawned (Ross et al. 2001). During the period,
the nutrition and energy metabolism of worm was especially
required for providing related substances to maintain normal
growth and eggs production. PRMT1 was therefore speculat-
ed to affect the nutrition and energy supplement in the devel-
opment and maturation course of shistosomula.
Numerous studies have reported that DCs are the most potent
antigen-presenting cells in the mammalian body and play a major
role in the initiation and regulation of the adaptive immune
response to pathogens [Martinez et al. 2007]. The function of
these cells in initiating immunity is largely dependent on the
Fig. 3 Recombinant SjcPRMT1 regulated expression of surface markers
of mouse BMDCs. CD11c+ cells were purified using anti-CD11c anti-
body conjugated beads. The purified DCs with LPS or rSjcPRMT-1
stimulation were stained with indicated mAb and analyzed on an open
gate for their phenotype by flow cytometry. Histograms represent one of
the three flow cytometry experiments
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expression ofMHC-II, CD40, CD80, andCD86 on the surface of
DCs themselves (Steinman 1991; Cella et al. 1997; Banchereau
and Steinman 1998; Straw et al. 2003). In vivo, only mature DCs
with high expression of these molecules can initiate immunity
(Lutz and Schuler 2002). We have shown that rSjcPRMT 1
induces DCs to mature via the upregulation of MHC-II, CD40,
CD80, andCD86 onDCs surface, whichwould initiate immunity
in vivo. This property makes rSj PRMT 1 a potential antigen
candidate, or adjuvant candidate, in the development of a new
vaccine. Hence, the results of this study demonstrate that
rSjcPRMT1 could induce mouse bone marrow-derived dendritic
cell (BMDC) to mature and therefore activate host immune
response. We suggest, therefore, that rSjcPRMI 1 may serve as
an effective candidate molecule for the development of a vaccine
against infection with S. japonicum .
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